| 产品名称 | Peptides EP05818_1 | HCMV pp65 417 – 426 (HLA-B*07:02) |
|---|---|
| 目录号 | EP05818_1 |
| 别名 | HCMV pp65 417 – 426 (HLA-B*07:02) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP05818_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP05818_1 | HCMV pp65 417 – 426 (HLA-B*07:02)
品名：HCMV pp65 417 – 426 (HLA-B*07:02)
货号：EP05818_1
规格：1 mg; 5 mg
品牌：Peptides.de
产品描述
Antigen Peptide CMV pp65 - HLA-B*07:02 (TPRVTGGGAM) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. CMV pp65 (415-429) (HLA-B7) is a CEF control peptide that is derived from the Cytomegalovirus (CMV). CMV is capable of infecting a wide range of human cell types, where the body’s primary immune response to CMV is innate, and relies on inflammatory cytokines and costimulatory molecules in order to control the spread of the virus. CMV pp65 (415-429) (HLA-B7) is defined as a CEF control peptide due to its antigenic properties. Clinically, these peptides are suitable epitopes for CD8+ T cells and can be used to stimulate the release of IFNg. HLA-B7 refers to the cell HLA type that this peptide acts on.
| Protein | 65 kDa phosphoprotein |
| Species | Human cytomegalovirus (Human herpesvirus 5) |
| Application | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication | Infectious disease, Cancer, Neuroscience, Diabetes |
